A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers

Keyphrases

• Targeted Therapy 100%
• Colorectal Cancer 100%
• Cutaneous Toxicity 100%
• Cetuximab 50%
• Epidermal Growth Factor Receptor Inhibitors 50%
• Multikinase Inhibitor 50%
• Premature Discontinuation 50%
• Anticancer Treatment 50%
• Regorafenib 50%
• Panitumumab 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Colorectal Cancer 100%
• Skin Toxicity 100%
• Symptom 50%
• Prematurity 50%
• Cetuximab 50%
• Epidermal Growth Factor Receptor Kinase Inhibitor 50%
• Regorafenib 50%
• Panitumumab 50%